Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dravniece

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The European Respiratory Journal|July 2, 2009
Adjunctive resectional lung surgery for extensively drug-resistant tuberculosisG Dravniece, K P Cain, T H Holtz, et al.
The European Respiratory Journal|February 27, 2010
Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004V Leimane, G Dravniece, V Riekstina, et al.
IJTLD Open|April 17, 2026
Experiences from Ukraine in expanding TB infection diagnosis and treatment, including for drug-resistant TBV Shukatka, L Skoklyuk, M Germanovych, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 31, 2020
Introducing bedaquiline: experiences from the Challenge TB ProjectC G Edwards, D F Wares, G Dravniece, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 28, 2018
QTc and anti-tuberculosis drugs: a perfect storm or a tempest in a teacup? Review of evidence and a risk assessmentI Monedero-Recuero, L Hernando-Marrupe, A Sánchez-Montalvá, et al.
IJTLD Open|July 5, 2024
Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European RegionG B Migliori, O Korotych, J Achar, et al.
BMC Public Health|July 17, 2021
Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patientsS E J van de Berg, P T Pelzer, A J van der Land, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The European Respiratory Journal|July 2, 2009
Adjunctive resectional lung surgery for extensively drug-resistant tuberculosisG Dravniece, K P Cain, T H Holtz, et al.
The European Respiratory Journal|February 27, 2010
Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004V Leimane, G Dravniece, V Riekstina, et al.
IJTLD Open|April 17, 2026
Experiences from Ukraine in expanding TB infection diagnosis and treatment, including for drug-resistant TBV Shukatka, L Skoklyuk, M Germanovych, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 31, 2020
Introducing bedaquiline: experiences from the Challenge TB ProjectC G Edwards, D F Wares, G Dravniece, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 28, 2018
QTc and anti-tuberculosis drugs: a perfect storm or a tempest in a teacup? Review of evidence and a risk assessmentI Monedero-Recuero, L Hernando-Marrupe, A Sánchez-Montalvá, et al.
IJTLD Open|July 5, 2024
Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European RegionG B Migliori, O Korotych, J Achar, et al.
BMC Public Health|July 17, 2021
Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patientsS E J van de Berg, P T Pelzer, A J van der Land, et al.
Pageof 1